Recruiting

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(16 sites)

United States

University of Colarodo Cancer Center, Aurora, Colorado

Mayo Clinic, Florida City, Florida

Duke University Medical Center - Duke Cancer Center, Durham, North Carolina

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania

The University of Texas MD Anderson Cancer Center, Texas City, Texas

Australia

The Queen Elizabeth Hospital, Woodville, Adelaide

Chris O'brien Lifehouse, Camperdown, New South Wales

Westmead Hospital, Westmead, New South Wales

Icon Cancer Centre, South Brisbane, Queensland

Flinders Medical Centre SA, Bedford Park, South Australia

Monash Health, Clayton, Victoria

Footscray Hospital - Western Health, Footscray, Victoria

Austin Health, Heidelberg, Victoria

Alfred Hospital, Melbourne, Victoria

Sunshine Hospital - Western Health, Saint Albans, Victoria

Sir Charles Gairdner Hospital, Nedlands, Western Australia